Long acting insulin for reducing cardiovascular morbidity and mortality in prediabetic patents and patients with Type 2 diabetes

Details for Australian Patent Application No. 2010202738 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Rosskamp, Ralf; Gerstein, Hertzel

Agent Watermark

Pub. Number AU-A-2010202738

Parent 2004206829

Filing date 30 June 2010

Wipo publication date 22 July 2010

International Classifications

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

22 July 2010 Application Open to Public Inspection

  Published as AU-A-2010202738

22 July 2010 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202739-A slide valve, in particular for blocking a line conveying media

2010202737-Substituted tetracycline compounds